Pasithea Therapeutics Corp. (KTTA) Live Share Price, Invest From India

Pasithea Therapeutics Corp. Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's High
$0.50
Day's Price Range
$0.52
$0.50
4.00%
Upside
52 Week's Low
52 Week's High
$0.28
52-Week Price Range
$2.06
$0.50
43.80%
Downside
312.00%
Upside

Pasithea Therapeutics Corp. share price movements today

Previous Close: $0.50
Open: $0.51
Volume: 500.4K
Day's Low - High: $0.50 - $0.52
52 Week Low - High: $0.28 - $2.06

Pasithea Therapeutics Corp. Historical Returns

1 Month Return: -28.84 %
3 Month Return: -36.07 %
1 Year Return: -35.45 %
3 Year Return: -94.79 %
5 Year Return: 0 %

Pasithea Therapeutics Corp. Stock Fundamentals & Key Indicators

Check Pasithea Therapeutics Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$16.8M

EPS (TTM)

-0.76

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-17.2M

Revenue (TTM)

486.6K

Profit Margin

0.00%

Return On Equity TTM

-58.22%

Pasithea Therapeutics Corp. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pasithea Therapeutics Corp. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Pasithea Therapeutics Corp.	BUY	$16.8M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Pasithea Therapeutics Corp. Stock including INR - Dollar returns

The Pasithea Therapeutics Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Pasithea Therapeutics Corp. investment value today

Current value as on today

₹70,865

Returns

-₹29,135

(-29.13%)

Returns from Pasithea Therapeutics Corp. Stock

-₹35,065 (-35.06%)

Dollar Impact

₹5,930 (+5.93%)

Analyst Recommendation on Pasithea Therapeutics Corp. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Pasithea Therapeutics Corp.. Average target price of $3

Pasithea Therapeutics Corp. Share Price Target

Get share price movements and forecasts by analysts on Pasithea Therapeutics Corp..

What analysts predicted

83.33%UPSIDE

Target Price

Current Price

$0.5

Analyzed by

7 Analysts

Target

$3.00

Pasithea Therapeutics Corp. target price $3, a slight upside of 83.33% compared to current price of $0.5. According to 7 analysts rating.

Indian Investors' Interest in Pasithea Therapeutics Corp. Stock

Search interest for Pasithea Therapeutics Corp. Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 20, 2026 to June 19, 2026

Change:-9% versus previous 30 day period

Pasithea Therapeutics Corp. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	-	-	-	0	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-5	-4	-3	-3	-3	-3	-3	-3	-10	-4
EBITDA	-4	-3	-3	-2	-3	-3	-3	-2	-10	-4
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-3	-3	-2	-3	-3	-3	-3	-10	-2
Income Tax Expense	0	0	0	-	0	-	-	-	-	-
Net Income	-5	-3	-3	-2	-3	-3	-3	-3	-10	-2
Net Profit Margin	-517.07%	0.00%	0.00%	0.00%	-489.60%	0.00%	0.00%	0.00%	0.00%	0.00%

Pasithea Therapeutics Corp. Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	-	-
Gross Profit	0	0	0	0	0
Operating Income	-4	-12	-15	-14	-20
EBITDA	-4	-11	-15	-13	-20
Interest Expense	0	0	-	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-2	-11	-15	-13	-20
Income Tax Expense	0	0	453	-	-
Net Income	-2	-13	-15	-13	-20
Net Profit Margin	-14430.49%	-2864.29%	-3280.52%	0.00%	0.00%

Pasithea Therapeutics Corp. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-3	-3	-2	-3	-3	-3	-3	-2,838	-2
Operating Cash Flow	-4	-4	-3	-2	-3	-3	-2	-5	-4
Investing Cash Flow	-	-	-	-	-	-	-	0	-
Financing Cash Flow	-	-	4	0	1	5	0	56	0
Change in Cash	-4	-4	1	-2	-1	1	-2	51	-4

Pasithea Therapeutics Corp. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-11	-15	-13	-20,427
Operating Cash Flow	-3	-13	-13	-13	-15,211
Investing Cash Flow	0	-2	0	-	11
Financing Cash Flow	55	-3	-3	4	63,518
Change in Cash	52	-19	-16	-9	48,337

Global Institutional Holdings in Pasithea Therapeutics Corp.

Funds	Holdings
Hurley Capital, LLC	0.01%
LPL Financial Corp	0.13%
Squadron Capital Management LLC	6.28%
Northern Trust Corp	0.06%
SBI Securities Co Ltd	0%

See all

Insights on Pasithea Therapeutics Corp.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -10.11M → -2.86M (in $), with an average increase of 252.4% per quarter
NO EFFECT
Against Peers
In the last 3 years, Pasithea Therapeutics Corp. Common Stock has experienced a drawdown of -94.8%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 72.7%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.8% return, outperforming this stock by 54.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 976.30K → 649.02K (in $), with an average decrease of 33.5% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, KTTA stock has moved down by -15.4%

About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumor; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Organisation	Pasithea Therapeutics Corp.
Headquarters	1111 Lincoln Road, Miami Beach, FL, United States, 33139
Industry	Biotechnology
CEO	Dr. Tiago Reis Marques M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Pasithea Therapeutics Corp.

Name	Title
Dr. Tiago Reis Marques M.D., Ph.D.	CEO & Director
Mr. Daniel H. Schneiderman	Chief Financial Officer
Dr. Kartik Krishnan M.D., Ph.D.	Chief Medical Officer
Dr. Lawrence Steinman BA, M.D., Ph.D.	Co-Founder & Executive Chairman

FAQs

What is Pasithea Therapeutics Corp. share price today?

Pasithea Therapeutics Corp. share price today is $0.5 as on June 19, 2026 at 8:45 am IST at the close of the market. Pasithea Therapeutics Corp. share today touched a day high of $0.52 and a low of $0.5.

What is the 52 week high and 52 week low for Pasithea Therapeutics Corp. share?

Pasithea Therapeutics Corp. share touched a 52 week high of $2.06 on November 28, 2025 and a 52 week low of $0.28 on November 21, 2025. Pasithea Therapeutics Corp. stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $0.5,which is 75.73% down from its 52 week high and 77.94% up from its 52 week low.

What is Pasithea Therapeutics Corp.'s market capitalisation today?

Pasithea Therapeutics Corp. market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in Pasithea Therapeutics Corp. Stock (KTTA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pasithea Therapeutics Corp. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pasithea Therapeutics Corp. Shares that will get you 3.0000 shares as per Pasithea Therapeutics Corp. share price of $0.5 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Pasithea Therapeutics Corp. Stock (KTTA) from India?

Indian investors can start investing in Pasithea Therapeutics Corp. (KTTA) shares with as little as ₹94.323 or $1 (as of June 19, 2026 at 1:58 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in Pasithea Therapeutics Corp. stock (as per the Rupee-Dollar exchange rate as on June 19, 2026 at 1:58 pm IST). Based on Pasithea Therapeutics Corp. share’s latest price of $0.5 as on June 19, 2026 at 8:45 am IST, you will get 20.0000 shares of Pasithea Therapeutics Corp.. Learn more about fractional shares .